Phase II evaluation of docetaxel plus exisulind in patients with androgen independent prostate carcinoma

Victoria J. Sinibaldi, Kathy Elza-Brown, Jill Schmidt, Mario A. Eisenberger, Eli Rosenbaum, Samuel R. Denmeade, Roberto Pili, Janet Walczak, Sharyn D. Baker, Marianna Zahurak, Michael A. Carducci

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Phase II evaluation of docetaxel plus exisulind in patients with androgen independent prostate carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences